Literature DB >> 28066070

IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES.

Robert S Gaston1.   

Abstract

Since the 1950s, care for kidney transplant recipients in the United States has evolved around a model in which clinical management, quality metrics, and financial underpinnings are focused around the surgical procedure itself reflecting the concept that perioperative and short-term interventions are primary determinants of success. In the current era, short-term results are indeed excellent, but long-term success remains elusive for many. Emerging data, particularly a newfound understanding of donor-specific antibody and its consequences, now challenge the concept that late graft failure is the consequence of early events. Several major longitudinal studies, including the long-term Deterioration of Kidney Allograft Function (DeKAF) project and Clinical Trials in Organ Transplantation-09 (CTOT-09), highlight the primacy of later events in influencing long-term outcomes after kidney transplantation. Proper long-term care and monitoring of kidney recipients, with timely diagnosis and treatment of identifiable injury, offers the best prospect of improving long-term graft survival.

Entities:  

Mesh:

Year:  2016        PMID: 28066070      PMCID: PMC5216502     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  45 in total

1.  Experiences with renal homotransplantation in the human: report of nine cases.

Authors:  D M HUME; J P MERRILL; B F MILLER; G W THORN
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

Review 3.  Rethinking chronic allograft nephropathy: the concept of accelerated senescence.

Authors:  P F Halloran; A Melk; C Barth
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

4.  The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival.

Authors:  C Wiebe; T E Nevins; W N Robiner; W Thomas; A J Matas; P W Nickerson
Journal:  Am J Transplant       Date:  2015-06-11       Impact factor: 8.086

5.  Home dialysis and the costs of uremia.

Authors:  D Rennie
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

6.  Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Authors:  Donald E Hricik; Richard N Formica; Peter Nickerson; David Rush; Robert L Fairchild; Emilio D Poggio; Ian W Gibson; Chris Wiebe; Kathryn Tinckam; Suphamai Bunnapradist; Milagros Samaniego-Picota; Daniel C Brennan; Bernd Schröppel; Osama Gaber; Brian Armstrong; David Ikle; Helena Diop; Nancy D Bridges; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2015-04-29       Impact factor: 10.121

7.  Report of a consensus conference on transplant program quality and surveillance.

Authors:  B L Kasiske; M A McBride; D L Cornell; R S Gaston; M L Henry; F D Irwin; A K Israni; N W Metzler; K W Murphy; A I Reed; J P Roberts; N Salkowski; J J Snyder; S C Sweet
Journal:  Am J Transplant       Date:  2012-06-08       Impact factor: 8.086

8.  The natural history of chronic allograft nephropathy.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

Review 9.  Call for revolution: a new approach to describing allograft deterioration.

Authors:  Philip F Halloran
Journal:  Am J Transplant       Date:  2002-03       Impact factor: 8.086

10.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

View more
  9 in total

1.  Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World Evidence.

Authors:  Ilkka Helanterä; Jon Snyder; Anders Åsberg; Josep Maria Cruzado; Samira Bell; Christophe Legendre; Hélio Tedesco-Silva; Giovanna Tedesco Barcelos; Yvonne Geissbühler; Luis Prieto; Jennifer B Christian; Erik Scalfaro; Nancy A Dreyer
Journal:  Transpl Int       Date:  2022-05-03       Impact factor: 3.842

2.  Outcomes of Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Our Experience Based on 35-Years Follow-Up.

Authors:  Tsung-Yin Tsai; Cheng-Hsu Chen; Ming-Ju Wu; Shang-Feng Tsai
Journal:  Diagnostics (Basel)       Date:  2022-05-08

3.  Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis.

Authors:  Hatem Ali; Karim M Soliman; Ihab Shaheen; Jon Jin Kim; Mohsen El Kossi; Ajay Sharma; Ravi Pararajasingam; Ahmed Halawa
Journal:  Int Urol Nephrol       Date:  2020-03-13       Impact factor: 2.370

4.  Providers' View on the First Kidney Transplantation Center in Ethiopia: Experience From Past to Present.

Authors:  Tariku Shimels; Abrham Getachew; Mekdim Tadesse; Alison Thompson
Journal:  Health Serv Res Manag Epidemiol       Date:  2021-05-25

5.  Exploring the Complexity of Death-Censored Kidney Allograft Failure.

Authors:  Manuel Mayrdorfer; Lutz Liefeldt; Kaiyin Wu; Birgit Rudolph; Qiang Zhang; Frank Friedersdorff; Nils Lachmann; Danilo Schmidt; Bilgin Osmanodja; Marcel G Naik; Wiebke Duettmann; Fabian Halleck; Marina Merkel; Eva Schrezenmeier; Johannes Waiser; Michael Duerr; Klemens Budde
Journal:  J Am Soc Nephrol       Date:  2021-04-21       Impact factor: 14.978

6.  The Impact of Different Induction Immunosuppressive Therapy on Long-Term Kidney Transplant Function When Measured by Iothalamate Clearance.

Authors:  Tambi Jarmi; Samir Khouzam; Nitika Shekhar; Meray Hosni; Launia White; David O Hodge; Martin L Mai; Hani M Wadei
Journal:  J Clin Med Res       Date:  2020-12-18

7.  Predictors and one-year outcomes of patients with delayed graft function after deceased donor kidney transplantation.

Authors:  Rao Chen; Haifeng Wang; Lei Song; Jianfei Hou; Jiawei Peng; Helong Dai; Longkai Peng
Journal:  BMC Nephrol       Date:  2020-12-04       Impact factor: 2.388

8.  Organization of Post-Transplant Care and the 5-Year Outcomes of Kidney Transplantation.

Authors:  Agnieszka Szymańska; Krzysztof Mucha; Maciej Kosieradzki; Sławomir Nazarewski; Leszek Pączek; Bartosz Foroncewicz
Journal:  Int J Environ Res Public Health       Date:  2022-02-11       Impact factor: 3.390

9.  Validation of a survival benefit estimator tool in a cohort of European kidney transplant recipients.

Authors:  Armando Coca; Carlos Arias-Cabrales; Ana Lucía Valencia; Carla Burballa; Juan Bustamante-Munguira; Dolores Redondo-Pachón; Isabel Acosta-Ochoa; Marta Crespo; Jesús Bustamante; Alicia Mendiluce; Julio Pascual; María José Pérez-Saéz
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.